RxDoctor Payments Data

Dimitrios Sigounas, MD

Neurological Surgery · Washington, DCNPI 1528228749

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,010 of the $3,106 with a category attached, or 64.7%. 20 manufacturers reported payments, led by Medical Device Business Services, Inc. at 27.5% of the total. Reporting peaked in 2022 at $1,444 and has fallen 97.2% since, to $41 in 2025.

$3,106in general payments, 2019–2025

Across 72 payments — averaging $43.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$854
  • Silk Road Medical, Inc.$500
  • Longeviti Neuro Solutions Inc$264
  • Medtronic$238
  • Boston Scientific$221
  • Stereotaxis Inc$201
  • plus $827 from 14 others
$95,640in research payments, 2019–2025

Across 33 payments — averaging $2898.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$62K
  • Penumbra, Inc.$34K

What the payments were for

  • Travel & lodging$1,09335%
  • Food & beverage$2,01065%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,106 in reported general payments places this provider in the 65th percentile of 31 neurological surgery providers in District of Columbia.

See all neurological surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$61,946
Medicare patients
71
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →